Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

NAActive, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Opioid Use DisorderInfectious DiseaseRisk Reduction BehaviorSubstance UseSubstance AbuseStimulant Use Disorder
Interventions
BEHAVIORAL

Patient Navigator

Linkage to services for OUD/SUD treatment including MOUD, Hepatitis C virus (HCV) testing and treatment; those not living with HIV infection will be provided access to PrEP services, and those living with HIV will receive assistance with gaining initial or continued access to ART services during the 6-month post-release intervention period

BEHAVIORAL

Mobile Health Unit

Participants will receive HIV PrEP/ HIV ART, MOUD, harm reduction services on the MHU and or assistance from a community health worker in linking to appropriate community-based OUD and other medical and behavioral health providers across the 6 month post-release intervention period

Trial Locations (3)

75390

UT Southwestern, Dallas

76129

Texas Christian University, Fort Worth

06510

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER